coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Canterbury South PCN, Canterbury · Health Inequalities Profile

    PCN U84081 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    46,702

    Registered population

    64.5% aged 18–64

    17.1%

    Aged 65+

    ICB 19.9% · England 17.9%

    14.9%

    Ethnic minority (non-White)

    5.6% Asian · England 9.6%

    17.5%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~7,615

    Core20 residents (est.)

    Resident basis; registered basis ~8,559 · see page 3

    5,782

    Hypertension register

    +8.75% in 3 yrs · England +5.60%

    479

    SMI register

    22.7% of Canterbury's

    555

    COPD register

    Reviews -2.53% in 3 yrs

    Forecast to 2030

    7,320

    Hypertension patients, 2030

    +1,538 on today

    63.3%

    QRISK ≥20% on statins, 2030

    +4.01pp over 3 yrs

    5.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    53.1%
    Asthma annual reviews trail England after three-year drop.

    Annual asthma reviews fell 10.0% over 3 years (England +4.4%) to 53.1% (England 65.7%), a 1,153 unreviewed scale indicator that may reflect recall gaps.

    54.3%
    High-risk lipid therapy and prescribing rates lag England.

    Lipid therapy reaches 54.3% for QRISK ≥ 20% (England 63.6%) and 63.5% in CKD (England 70.3%), with 1,270 adult lipid items/1,000 (England 4,100).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age patients comprise 64.5% of the list alongside 733 catchment care home beds

    Canterbury South PCN serves 46,702 registered patients across three practices. Working-age adults (18–64) comprise 64.5% (Canterbury 62.9%, NHS Kent and Medway ICB 59.5%, England 62.7%), while patients aged 65+ represent 17.1% (7,982 patients; Canterbury 18.4%, ICB 19.9%, England 17.9%). Census usual residents in associated areas—not registered patients—are 85.1% White (England 81.1%), 5.6% Asian (England 9.6%) and 3.9% Black (England 4.2%). Recorded learning disability prevalence is 0.4% (Canterbury 0.6%, England 0.6%), with 0.2% at University Medical Centre and 0.4% at Canterbury Medical Practice.

    Age profile

    0–1718.4%
    18–6464.5%
    65+17.1%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White85.1%
    Asian5.6%
    Black3.9%
    Mixed3.4%
    Other2.1%

    Older people · falls rows are Canterbury local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Canterbury LA)1,5772,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Canterbury LA)6829819552024/25
    Falls deaths, all ages, per 100,000 (Canterbury LA)18.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 averages 17.5% across the PCN but reaches 34.2% at New Dover Road Surgery

    The PCN Core20 share is 17.5%, below Canterbury (19.3%), above NHS Kent and Medway ICB (17.1%) and below England (21.0%). Practice shares span 20.8 pp: New Dover Road Surgery holds the highest concentration at 34.2% (3,526 estimated patients), while Canterbury Medical Practice accounts for an estimated 3,372 patients (14.1%). An estimated 7,615 residents live in deciles 1 and 2, though weighted practice shares (18.3%) differ by 0.84 percentage points. Outreach should balance concentrated deprivation at New Dover Road Surgery with high overall volume at Canterbury Medical Practice.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    New Dover Road34.2% · 3,526 patients
    Canterbury14.1% · 3,372 patients
    University13.3% · 1,661 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    479

    SMI register

    0.97% recorded prevalence

    182

    Learning disability register

    0.37% recorded prevalence

    28

    Care homes, 733 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Canterbury, Census 2021

    The PCN records 479 severe mental illness patients (1.0%, matching England 1.0%) and 182 on the learning disability register (0.4%; England 0.6%), alongside 28 catchment care homes (733 beds). Local authority snapshot data records 29 rough sleepers in autumn 2025, while applying the borough unpaid-care rate yields an estimated ceiling of 4,343 carers. Trailing learning disability prevalence could reflect coding differences that an audit would test.

    Severe mental illness: physical health checks

    Recorded severe mental illness check elements trail England: blood pressure checks reached 76.7% (England 83.4%) and body mass index 76.2% (England 82.1%). This is consistent with recall gaps that comprehensive physical health check reviews would clarify.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,782

    Hypertension register

    +8.75%

    Register growth, 3 yrs

    Canterbury +3.48% · England +5.60%

    +3.52pp

    BP control, under 80

    ≤140/90 · +1.64pp aged 80+

    +1,538

    More patients by 2030

    Forecast 7,320 (13.86%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 11.7% (5,782 patients), below Canterbury (15.6%), NHS Kent and Medway ICB (16.2%) and England (15.2%). Recent blood pressure recording reaches 86.4% (England 90.0%), and treatment to target is 66.8% (England 70.3%). Among patients aged under 80, control to <= 140/90 mmHg is 63.5% (England 67.8%), spanning from 68.0% at New Dover Road Surgery to 62.1% at Canterbury Medical Practice and 60.6% at University Medical Centre. Control for patients aged 80 and over is 77.3% (England 81.2%). Observation periods are unconfirmed, and crude prevalence differences do not establish undiagnosed disease. Trailing national benchmarks across age groups could reflect recall or titration differences that a clinical audit would test.

    Lipids and statins

    Lipid-lowering therapy reaches 54.3% for QRISK ≥ 20% (England 63.6%) and 63.5% in CKD (England 70.3%). Statin therapy in diabetes with CVD is 79.0% (England 84.4%), after falling 1.4 pp over three years (England +0.8 pp). These gaps against England could reflect review or prescribing recall patterns that a clinical audit would clarify.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202648,413£2.00£1.90£1.86£96,826
    Cardiovascular (all), 202571,455£4.01£3.57£3.33£286,535

    For lipid-regulating drugs in 2026, the PCN prescribed 48,413 items at £2.00 per item (Canterbury £2.23, NHS Kent and Medway ICB £1.90, England £1.86). The PCN spends £6,778 more than at England's unit cost across these items. This unit-cost indicator does not establish inefficiency, though local formulary choices could be reviewed to verify mix.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −9.99%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.85%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual reviews fell 10.0% over three years (England +4.4%) to 53.1%, trailing England (65.7%), NHS Kent and Medway ICB (60.4%) and Canterbury (56.4%), leaving about 1,200 register patients unreviewed (1,153 on a register of 2,457). Youth asthma prescribing reached 976 items per 1,000 aged 5-19 against 1,488 in England. In contrast, COPD reviews reached 76.4%, matching England (76.4%) on a register of 555 patients (1.1% prevalence). This divergence could reflect differing recall processes that an audit of disease registers would test.

    Cancer register and children's immunisation

    Cancer register prevalence is 3.8% (1,886 patients), matching England (3.8%). In Q1 2025/26, 6-in-1 coverage at 24 months reached 97.5% (England 92.2%), above the 95.0% target. At age 5, second-dose MMR is 91.8% (4.7 pp below first-dose 96.5%, cohort 85) and 4-in-1 booster is 89.4%, below the 95.0% target by 5.6 pp. This drop could reflect pre-school recall attrition that practice-level audit would test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.2%

    England 91.0%

    6-in-1 complete primary course at 24 months97.5%

    England 92.2%

    MMR dose 1 at 24 months89.9%

    England 88.3%

    MMR dose 2 at age 591.8%

    England 82.8%

    4-in-1 pre-school booster at age 589.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of cancers with a known stage in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (England 55.3%), showing a distance of -19.4 pp to the 75.0% national ambition by 2028 (a gap of 1,627 early-stage cases across the ICB). Staging data reflects system diagnosis rather than PCN performance, and coverage is incomplete: only 63.6% of registered cancers had a recorded stage (England 67.0%). Canterbury South PCN cancer prevalence is 3.8% (1,886 patients), rising +15.6% over three years (England +9.0%). Cervical screening (ages 25-49) reached 66.9% (ICB 69.9%), ranging from 59.8% at University Medical Centre to 70.2% at Canterbury Medical Practice.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, East Kent Hospitals University NHS Foundation Trust achieved 70.0% on the 62-day cancer standard against the 85.0% standard (ICB 75.9%, England 71.2%; East Sussex Healthcare NHS Trust 67.0%, Medway NHS Foundation Trust 81.6%). On the 28-day faster diagnosis standard, East Kent reached 71.3% against the 75.0% standard (ICB 76.8%, England 79.3%). For diagnostic waits in July 2026, 48.4% of patients at East Kent waited 6+ weeks across all tests (East Sussex Healthcare NHS Trust 5.3%, Medway NHS Foundation Trust 14.2%, England 23.1%). Provider waits reflect acute system pressures rather than PCN performance.

    Pathways within standard (%)East KentMedwayEast Sussex HealthcareKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2877.7784.2076.7879.32
    31-day treatment (96%)96.6799.6298.1995.8492.50
    62-day referral to treatment (85%)70.0181.6467.0475.9371.16
    Diagnostic waits over 6 weeks (%)East KentMedwayEast Sussex HealthcareEngland
    MRI47.580.686.4821.40
    CT37.450.000.489.92
    Echocardiography14.1736.6221.9428.48
    Colonoscopy9.581.880.7430.83
    Gastroscopy22.163.320.3129.02
    All 15 DM01 tests48.3814.205.2723.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026, provisional experimental statistics recorded 265,905 community care activities for residents of Kent and 297,595 across NHS Kent and Medway Integrated Care Board. Contacts with adults aged 65 and over represented 65.8% of contacts among borough residents. These experimental figures reflect submitting providers for local authority residents and the wider system, rather than an exclusive PCN patient cohort.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    QOF vaccination achievement spans 69.0 pp across practices despite uniform 100.0% clinical achievement

    In 2025/26, QOF clinical achievement reached 100.0% at Canterbury Medical Practice, New Dover Road Surgery and University Medical Centre (England 97.1%). However, vaccination achievement spanned 69.0 pp, from 25.0% at New Dover Road Surgery to 94.0% at University Medical Centre (Canterbury Medical Practice 58.5%; England 55.2%). Personalised care adjustments ranged from 10.7% to 15.9% (England 10.0%), consistent with operational variation.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    New Dover Road9234.258.9%63.7%86.5%
    University12513.371.5%74.7%79.7%
    Canterbury12214.137.3%70.3%74.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCanterburyAssetPCNCanterbury
    Care homes (catchment)28 (733 beds)n/aSchools (catchment)85n/a
    Children's centres38Places of worship84103
    Libraries22Food banks (VCS)1no data
    Day centres (VCS)54Children and young people (VCS)n/a1
    Carers support groups (VCS)34Primary schools (LA maintained)1719
    Primary academies1013Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual reviews are 53.1% (Canterbury 56.4%, NHS Kent and Medway ICB 60.4%, England 65.7%), falling 10.0% over 2023 to 2025 (England +4.4%), with 1,153 unreviewed on a 2,457 register. For discussion, the PCN could run a single-template asthma recall and inhaler check across practices with flexible slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school booster and LD register audit

    In Q1 2025/26, age-5 MMR2 is 91.8% vs 96.5% MMR1 (4.7 pp difference; New Dover Road Surgery 9.5 pp) and 4-in-1 is 89.4% (below 95.0% by 5.6 pp). LD prevalence is 0.4% (182 patients; England 0.6%), falling 3.0% (England +5.4%). Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    CVD lipid, BP and SMI recall

    Lipid therapy is 54.3% for QRISK ≥ 20% (England 63.6%), 63.5% in CKD (England 70.3%) and 79.0% in diabetes with CVD (-1.4 pp). Under-80 BP control is 63.5% (England 67.8%; University Medical Centre 60.6%) and SMI BP checks are 76.7% (England 83.4%). Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register audit (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation call-recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Pre-school booster and LD register audit (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 575% annual health checks (Network Contract DES) · Oliver McGowanPCN & Practice
    Option 3 · CVD lipid, BP and SMI recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029 · MHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15